Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.02 | N/A |
| PEG Ratio (TTM) | -0.74 | N/A |
| P/S Ratio (TTM) | 1.21 | N/A |
| P/B Ratio (TTM) | 0.65 | N/A |
| P/FCF Ratio (TTM) | 3.66 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.59 | N/A |
| Price to 5YR AVG FCF Ratio | 2.05 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.69% | N/A |
| ROE (TTM) | 6.68% | N/A |
| Net Profit Margin (TTM) | 12.24% | N/A |
| ROIC 5YR AVG | 9.43% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.87% | 84.48% | 48.39% |
| Revenue | 128.45% | 4.50% | 10.40% |
| Net Income | 24.75% | 80.91% | 48.14% |
| Cash Flow | 316.90% | 102.68% | 48.83% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 15.12 | N/A |
| Quick Ratio (TTM) | 15.12 | N/A |
| D/E Ratio (TTM) | 0.70 | N/A |
| Interest Coverage (TTM) | 0.51 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.51 | N/A |
| LTL to 5YR AVG FCF | 1.59 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.84% | N/A |